Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

All-trans retinoic acid slows cell growth and increases cell death in goat hair follicles through a specific pathway.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

Recent advances in hair loss treatments show significant progress.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

An 11-year-old girl's hair regrew after treating her thyroid condition with carbimazole.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

People with alopecia areata may have a higher risk of thyroid diseases.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Trichofolliculoma is a unique benign tumor mainly affecting middle-aged adults' faces, often misdiagnosed without histopathology.

TGF-β1 and 2 may play a role in hair loss in AGA.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Patients with alopecia areata had higher TSH levels.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

Focal atrichia helps diagnose female pattern hair loss.

The patient with autoimmune hypothyroidism improved after treatment for thyroid and associated conditions.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Lupus and frontal fibrosing alopecia may share a common cause.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Topical tacrolimus did not regrow hair in alopecia universalis patients.